The Adjutor Group: Specialist regulatory consultants Australia, working with global SMEs for end-to-end development and commercialisation of medicines and medical devices.

The
Adjutor Group

The Adjutor Group is a leading healthcare services company operating globally.


No matter what your stage of product development or lifecycle, we can provide an experienced, tailored team to support your business objectives.

Regulatory Affairs and Market Access | TGA Regulatory Affairs Consultants Australia: Adjutor are experts in regulatory affairs and market access, able to guide you to market efficiently and effectively.
Sponsorship and Commercialisation | Adjutor can help you to you access a wide variety of countries and ensure effective commercialisation and product launch strategies. North and Latin America, Europe/UK, Asia/Pacific, Middle East.
Quality and Training | Whether your existing quality system needs a refresh or you’re just embarking on your first quality journey, Adjutor can help with documentation, training and auditing.

Quality and Training

We provide QMS system design & implementation that is fit for your purposes, training of staff in the QMS together with a variety of auditing solutions.

Adjutor Healthcare Strategy and Project Management | Strategy is key to everything we do! Development, regulatory, commercialisation, and market access strategy. Integrated project plans and ongoing project management.

Strategy and Project Management

Strategy is key to everything we do. We will design a focused plan of how to achieve your commercial product vision.

Adjutor Healthcare are specialists in drug and device development requirements, including lab, non-clinical and clinical, as well as acting as a CRO.

Drug and Device Development

We are specialists in drug and device development requirements, including lab, non-clinical and clinical, as well as acting as a CRO.

Adjutor Clinical provides comprehensive clinical trial services for medicines, medical devices and cell and gene therapies, to smooth your path to product approvals globally.

Clinical Trial Services

Adjutor Clinical provides comprehensive clinical trial services for medicines, medical devices and cell and gene therapies.

Adjutor handle all aspects of clinical trial preparation, from planning and protocol development to securing permits and ensuring regulatory readiness, so your studies start on the right track.
The Adjutor clinical trial operations team ensures your studies run smoothly from start to finish. We manage site setup, monitoring, logistics, and compliance, keeping your trials on track and delivering high-quality data.

Risk Management

Registration Pathways

QMS System Design

Data Analytics

Why Choose Us?


We get SMEs and the Adjutor Advantage is how we demonstrate, every day, that we are a great partner for your business. We’re engaged, and motivated, to help you at each stage of your journey to market and beyond.

Learn More About Us

Excellent quality, timeliness and responsiveness. Polite and helpful. Really felt like one team.

EU Based Biopharmaceutical Company

Our partnership and collaboration with the Adjutor Healthcare team has been phenomenal and has contributed to our successes in Australia, Singapore, and South Korea.

USA Based Biopharmaceutical Company

The consultants are “very knowledgeable, proactive collaborative and excellent communicators.

USA Based Biopharmaceutical Company

My experience over the last couple of years has been very positive and I can’t think of any areas of improvement.

USA Based Biopharmaceutical Company

Very collaborative teams who asked intelligent questions and thought ahead.

EU Based Biopharmaceutical Company

The consultants I work with at Adjutor are “just amazing, responding very quickly, very organised, highly knowledge” … with projects “delivered on time and with high quality standards.

USA Based Biopharmaceutical Company

Latest Insights

  • Regulatory Strategy for Drug and Device Development

    Regulatory Strategy for Drug and Device Development

    Regulatory Strategy for Drug and Device Development. Why it must start on Day One. In the fast-paced world of life sciences innovation, the drive to “get moving” can be irresistible. Teams dive into development, eager to demonstrate progress.Yet the companies that succeed long-term are those that pause first to plan, align, and build a regulatory…

  • China Drug Regulation Updates 2026

    China Drug Regulation Updates 2026

    China Drug Regulation Updates 2026 – Strategic Implications for International Biopharma and MedTech China has recently updated the implementing regulations under its Drug Administration Law. The changes reflect a continued shift toward encouraging pharmaceutical innovation while strengthening regulatory oversight across the full product lifecycle. On January 27, 2026, the State Council promulgated the revised “Regulations for the…

  • 2025 A Year in Review

    2025 A Year in Review

    As we approach the close of 2025, it’s essential to reflect on our achievements, growth, and the incredible progress we’ve made together. This year has been transformative, marked by milestones that position The Adjutor Group for even greater success in 2026. As we look forward, we remain committed to innovation, collaboration, and delivering exceptional value…

Contact us today and let’s work together to achieve your goals. Whether you have a question, need more information, or want to discuss your project, our team is here to help.